Mylan

To complete the application, the agency noted that an inspection of the manufacturing facility is required as a part of the…

The European Commission decision on the approval is expected early next year

Transaction expected to be immediately accretive to Mylan upon closing and is anticipated to be accretive to VIATRIS

It has also recommended the company to engage a cGMP Consultant

Mylan is offering Semglee at a wholesale acquisition cost (WAC) of $147.98 per package of five 3ml pens and $98.65 per 10ml vial

Pharma companies awarded for their exemplary work during COVID-19 crisis

Etanercept was first approved for the treatment of rheumatoid arthritis in Germany in 2000 and since then has offered an effective…

Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS)

Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be…

According to figures compiled by the CDSCO, India will be producing 20,000 vials per day by the end of July.